By Rob Curran
Thermo Fisher Scientific posted 14% net-income growth in the first quarter as revenue inched up and costs remained stable.
The Waltham, Mass., maker of microscopes and other life-sciences and laboratory equipment said earnings rose to $1.51 billion, or $3.98 a share, from $1.33 billion, or $3.46 a share, a year earlier.
Excluding certain one-off items, Thermo posted adjusted earnings of $5.15 a share, topping the average Wall Street peg of $5.10 a share, according to FactSet.
Revenue rose 0.2% to $10.36 billion, ahead of the average analyst estimate of $10.23 billion. Cost of revenue rose slightly to $6.06 billion, but was stable, at 58.4%, as a percentage of revenue.
Manufacturers are monitoring tariff negotiations because of the implications for costs.
In a statement, Chairman, President and Chief Executive Marc Casper expressed confidence in the company's ability to "manage the current environment."
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
April 23, 2025 06:18 ET (10:18 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.